Total Payments
$10,104
2024 Payments
$856.66
Companies
44
Transactions
582
Medicare Patients
2,015
Medicare Billing
$125,317
Payment Breakdown by Category
Food & Beverage$9,866 (97.6%)
Education$238.44 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,866 | 574 | 97.6% |
| Education | $238.44 | 8 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,168 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,078 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $946.94 | 48 | $0 (2024) |
| PFIZER INC. | $754.85 | 62 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $697.94 | 46 | $0 (2023) |
| Novo Nordisk Inc | $641.17 | 39 | $0 (2024) |
| Astellas Pharma US Inc | $575.76 | 22 | $0 (2024) |
| ABBVIE INC. | $477.91 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $431.13 | 29 | $0 (2022) |
| Amarin Pharma Inc. | $353.30 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $856.66 | 38 | Lilly USA, LLC ($223.57) |
| 2023 | $1,741 | 83 | GlaxoSmithKline, LLC. ($307.00) |
| 2022 | $1,317 | 75 | ABBVIE INC. ($175.17) |
| 2021 | $1,420 | 74 | Astellas Pharma US Inc ($236.41) |
| 2020 | $791.42 | 47 | AstraZeneca Pharmaceuticals LP ($122.47) |
| 2019 | $1,470 | 92 | GlaxoSmithKline, LLC. ($182.45) |
| 2018 | $1,247 | 80 | GlaxoSmithKline, LLC. ($150.79) |
| 2017 | $1,261 | 93 | AstraZeneca Pharmaceuticals LP ($186.99) |
All Payment Transactions
582 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: PAIN | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: Cardiovascular | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Biological | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: PAIN | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Diabetes | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.68 | General |
| Category: Cardiovascular | ||||||
| 06/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: PAIN | ||||||
| 06/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Biological | ||||||
| 05/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.84 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 529 | 553 | $103,205 | $43,890 |
| 2022 | 9 | 473 | 524 | $96,530 | $22,804 |
| 2021 | 11 | 496 | 559 | $90,730 | $23,782 |
| 2020 | 15 | 517 | 572 | $85,224 | $34,841 |
Total Patients
2,015
Total Services
2,208
Medicare Billing
$125,317
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $46,875 | $15,454 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 119 | $19,635 | $9,378 | 47.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 32 | 32 | $12,000 | $5,060 | 42.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 18 | $6,250 | $3,800 | 60.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $6,975 | $3,738 | 53.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 51 | $6,375 | $3,299 | 51.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $1,575 | $1,328 | 84.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 44 | 44 | $1,320 | $900.24 | 68.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 64 | 64 | $1,600 | $511.78 | 32.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 24 | 24 | $600.00 | $422.40 | 70.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 164 | $26,110 | $7,119 | 27.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 83 | 83 | $31,125 | $4,100 | 13.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 53 | 53 | $19,875 | $3,397 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 62 | $7,075 | $2,547 | 36.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 19 | $5,550 | $1,808 | 32.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 23 | 26 | $3,250 | $1,455 | 44.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $1,470 | $1,197 | 81.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 44 | 44 | $1,320 | $883.08 | 66.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 31 | $755.00 | $297.89 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 168 | $22,680 | $7,933 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 129 | 129 | $48,375 | $6,905 | 14.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 50 | $5,000 | $2,409 | 48.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $4,200 | $1,923 | 45.8% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 16 | 17 | $3,910 | $1,322 | 33.8% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 35 | 35 | $1,050 | $693.89 | 66.1% |
About Dr. Yahya Hashmi, MD
Dr. Yahya Hashmi, MD is a Internal Medicine healthcare provider based in Lewiston, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861433930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yahya Hashmi, MD has received a total of $10,104 in payments from pharmaceutical and medical device companies, with $856.66 received in 2024. These payments were reported across 582 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($9,866).
As a Medicare-enrolled provider, Hashmi has provided services to 2,015 Medicare beneficiaries, totaling 2,208 services with total Medicare billing of $125,317. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lewiston, NY
- Active Since 06/09/2006
- Last Updated 04/27/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1861433930
Products in Payments
- JARDIANCE (Drug) $695.96
- MOUNJARO (Drug) $461.82
- FARXIGA (Drug) $438.72
- TRELEGY ELLIPTA (Drug) $423.66
- ELIQUIS (Drug) $409.20
- Vascepa (Drug) $368.93
- ENTRESTO (Drug) $281.29
- TRULICITY (Drug) $269.24
- AREXVY (Drug) $238.81
- NURTEC ODT (Drug) $237.66
- Saxenda (Drug) $224.28
- STIOLTO RESPIMAT (Drug) $217.22
- XARELTO (Drug) $199.77
- CHANTIX (Drug) $193.49
- TRINTELLIX (Drug) $187.33
- Veozah (Drug) $183.74
- UBRELVY (Drug) $160.14
- Livalo (Drug) $154.33
- Yupelri (Drug) $129.07
- JANUVIA (Drug) $126.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lewiston
Dr. Philip Sauvageau, M.d, M.D
Internal Medicine — Payments: $6,873
Internal Medicine $6,873
Tai Ho Shin, Md, MD
Internal Medicine — Payments: $6,556
Internal Medicine $6,556
Clinton Morgan, Md, MD
Internal Medicine — Payments: $1,788
Internal Medicine $1,788
Dr. Barbara Davis, Md, MD
Internal Medicine — Payments: $1,696
Internal Medicine $1,696
Patricia Brady, Md, MD
Internal Medicine — Payments: $1,488
Internal Medicine $1,488
Dr. Gregory English, Do, DO
Internal Medicine — Payments: $816.69
Internal Medicine $816.69